Codexis Signs Agreement with Pioneer siRNA Drug Innovator
Codexis Signs Agreement for Cardiovascular Indication
Evolve beyond solid-phase oligonucleotide synthesis (SPOS) with a modern and efficient approach that delivers higher quality, greater scale, and better manufacturability
Transform complex, resource-intensive processes into precise, sustainable breakthroughs with biocatalysis that scales from grams to tonnes
Precision-tuned enzyme solutions enhance fidelity, selectivity, and activity for applications that demand superior performance